About Us
Nanophysics & Beyond
Curadigm
The Management
Our Commitments
Healthcare Professionals
Scientific Publications
Patients
Patient Engagement
Shareholders
Corporate Presentation
Financial Calendar
Regulated Information
Annual General Meetings
Shareholder Corner
Press Releases
Congresses & Events
Nanotalks
NBTXR3 Development
R&D Day
Our Expert Videos
Nanoblog
From Curie to Nano
Contact & Newsletter
Medical Device Vigilance – Pharmacovigilance
Medical Information
Join Us
Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
Continuer
Rester sur la page
Financial | Revenue for the 1st quarter of 2016
Financial | Nanobiotix 2015 Annual Results
29 April 2016
Scientific Clinical | Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology
31 May 2016
Financial | Revenue for the 1st quarter of 2016
Published by
adminvl
on
13 May 2016
No translations available for this page
